{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:19:13Z","timestamp":1787847553108,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The aim of the study is to investigate the factors affecting acute hematologic toxicity (HT) in the adjuvant radiotherapy (RT) of gynecologic cancers by machine learning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Between January 2015 and September 2018, 121 patients with endometrium and cervical cancer who underwent adjuvant RT with volumetric-modulated arc therapy (VMAT) were evaluated. The relationship between patient and treatment characteristics and acute HT was investigated using machine learning techniques, namely Logistic Regression, XGBoost, Artificial Neural Network, Random Forest, Naive Bayes, Support Vector Machine (SVM), and Gaussian Naive Bayes (GaussianNB) algorithms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>No HT was observed in 11 cases (9.1%) and at least one grade of HT was observed in 110 cases. There were 55 (45.5%) cases with \u2264grade 2 HT (mild HT) and 66 (54.5%) cases with grade \u22653 HT (severe HT). None of the patients developed grade 5 HT. Of 24 variables that could affect acute HT, nine were determined as important variables. According to the results, the best machine learning technique for acute HT estimation was SVM (accuracy 70%, area under curve (AUC): 0.65, sensitivity 71.4%, specificity 66.6%). Parameters affecting hematologic toxicity were evaluated also by classical statistical methods and there was a statistically significant relationship between age, RT, and bone marrow (BM) maximum dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>It is important to predict the patients who will develop acute HT in order to minimize the side effects of treatment. If these cases can be identified in advance, toxicity rates can be reduced by taking necessary precautions. These cases can be predicted with machine learning algorithms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijc.ijc_666_19","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T15:22:10Z","timestamp":1625152930000},"page":"178-186","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of acute hematological toxicity by machine learning in gynecologic cancers using postoperative radiotherapy"],"prefix":"10.4103","volume":"59","author":[{"given":"Melek","family":"Akcay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durmus","family":"Etiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozer","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaattin","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240828","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-4-20240828","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12185-015-1920-z","article-title":"Human bone marrow mesenchymal stromal\/stem cells: Current clinical applications and potential for hematology","volume":"103","author":"Miura","year":"2016","journal-title":"Int J Hematol"},{"key":"R4-4-20240828","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.1015350108","article-title":"Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells","volume":"108","author":"Cao","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R5-4-20240828","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1088\/0031-9155\/5\/3\/302","article-title":"The distribution of active bone marrow in the adult","volume":"5","author":"Ellis","year":"1961","journal-title":"Phys Med Biol"},{"key":"R6-4-20240828","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-4-20240828","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1148\/radiology.194.2.7824737","article-title":"Female pelvic bone marrow: Serial MR imaging before, during, and after radiation therapy","volume":"194","author":"Blomlie","year":"1995","journal-title":"Radiology"},{"key":"R8-4-20240828","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","article-title":"Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies","volume":"48","author":"Roeske","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-4-20240828","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0090-8258(03)00461-X","article-title":"Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: A comparative dosimetric study of dose-volume histograms","volume":"91","author":"Heron","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R10-4-20240828","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ijrobp.2008.04.046","article-title":"Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer","volume":"71","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-4-20240828","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2009.11.010","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy","volume":"79","author":"Rose","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-4-20240828","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2009.12.025","article-title":"Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT","volume":"79","author":"Albuquerque","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-4-20240828","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10555-015-9555-3","article-title":"Five critical elements to ensure the precision medicine","volume":"34","author":"Chen","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"R14-4-20240828","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMe1213371","article-title":"A glimpse of the next 100 years in medicine","volume":"26","author":"Kohane","year":"2012","journal-title":"N Engl J Med"},{"key":"R15-4-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrclinonc.2012.196","article-title":"Predicting outcomes in radiation oncology\u2013 multifactorial decision support systems","volume":"10","author":"Lambin","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R16-4-20240828","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus guidelines for delineation of clinical target volume for intensity- modulated pelvic radiotherapy for definitive treatment of cervix cancer","volume":"79","author":"Lim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-4-20240828","first-page":"2229","article-title":"Evaluation: From precision, recall and F-measure to ROC, informedness, markedness and correlation","volume":"2","author":"Powers","year":"2011","journal-title":"J Mach Learn Technol"},{"key":"R18-4-20240828","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1118\/1.2818738","article-title":"Volumetric modulated arc therapy: IMRT in a single gantry arc","volume":"35","author":"Otto","year":"2008","journal-title":"Med Phys"},{"key":"R19-4-20240828","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1016\/j.radonc.2008.06.013","article-title":"A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy","volume":"89","author":"Cozzi","year":"2008","journal-title":"Radiother Oncol"},{"key":"R20-4-20240828","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00066-002-0951-6","article-title":"Second primary tumors after radiotherapy for malignancies. Treatment-related parameters","volume":"178","author":"D\u00f6rr","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"R21-4-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","article-title":"Intensity-modulated radiation therapy, protons, and the risk of second cancers","volume":"65","author":"Hall","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-4-20240828","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fonc.2019.00760","article-title":"Clinical outcomes of volumetric modulated arc therapy following intracavitary\/interstitial brachytherapy in cervical cancer: A single institution retrospective experience","volume":"16","author":"Lin","year":"2019","journal-title":"Front Oncol"},{"key":"R23-4-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41232-017-0049-2","article-title":"Effects of acute exposure to low-dose radiation on the characteristics of human bone marrow mesenchymal stromal\/stem cells","volume":"37","author":"Fujishiro","year":"2017","journal-title":"Inflamm Regen"},{"key":"R24-4-20240828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2018.01.054","article-title":"Machine learning on a genome-wide association study to predict late genitourinary toxicity after prostate radiation therapy","volume":"101","author":"Lee","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-4-20240828","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1088\/0031-9155\/61\/16\/6105","article-title":"Using machine learning to predict radiation pneumonitis in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"16","author":"Valdes","year":"2016","journal-title":"Phys Med Biol"},{"key":"R26-4-20240828","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2016.05.015","article-title":"Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy","volume":"120","author":"Dean","year":"2016","journal-title":"Radiother Oncol"},{"key":"R27-4-20240828","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1088\/1361-6560\/aa8d09","article-title":"Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: A feasibility study","volume":"62","author":"Zhen","year":"2017","journal-title":"Phys Med Biol"},{"key":"R28-4-20240828","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13014-018-1068-0","article-title":"Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy","volume":"13","author":"Chen","year":"2018","journal-title":"Radiat Oncol"},{"key":"R29-4-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_666_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:21:33Z","timestamp":1787844093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_666_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_666_19","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}